Aspire Private Capital’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.25M Sell
8,960
-170
-2% -$36.6K 0.47% 48
2026
Q1
$1.99M Buy
9,130
+1,047
+13% +$232K 0.45% 50
2025
Q4
$1.85M Sell
8,083
-214
-3% -$48.7K 0.41% 54
2025
Q3
$1.92M Buy
8,297
+740
+10% +$151K 0.42% 53
2025
Q2
$1.4M Sell
7,557
-415
-5% -$77.1K 0.33% 69
2025
Q1
$1.67M Buy
7,972
+670
+9% +$130K 0.42% 53
2024
Q4
$1.3M Buy
7,302
+756
+12% +$139K 0.32% 59
2024
Q3
$1.29M Buy
6,546
+304
+5% +$56.7K 0.31% 59
2024
Q2
$1.07M Buy
6,242
+620
+11% +$103K 0.28% 60
2024
Q1
$1.02M Buy
5,622
+515
+10% +$88.8K 0.27% 62
2023
Q4
$792K Buy
5,107
+186
+4% +$27.1K 0.23% 66
2023
Q3
$734K Buy
4,921
+80
+2% +$11.7K 0.24% 60
2023
Q2
$652K Buy
4,841
+18
+0.4% +$2.64K 0.21% 79
2023
Q1
$769K Sell
4,823
-458
-9% -$70K 0.26% 50
2022
Q4
$853K Buy
5,281
+123
+2% +$18.9K 0.31% 44
2022
Q3
$692K Sell
5,158
-239
-4% -$34.3K 0.26% 48
2022
Q2
$827K Sell
5,397
-84
-2% -$12.8K 0.3% 45
2022
Q1
$889K Sell
5,481
-1,441
-21% -$209K 0.28% 43
2021
Q4
$937K Buy
6,922
+175
+3% +$20.7K 0.29% 45
2021
Q3
$728K Buy
6,747
+377
+6% +$43.1K 0.24% 51
2021
Q2
$718K Sell
6,370
-672
-10% -$75.7K 0.23% 53
2021
Q1
$762K Sell
7,042
-469
-6% -$50.2K 0.27% 53
2020
Q4
$805K Sell
7,511
-35
-0.5% -$3.36K 0.31% 58
2020
Q3
$661K Sell
7,546
-15
-0.2% -$1.41K 0.27% 63
2020
Q2
$743K Sell
7,561
-814
-10% -$71.7K 0.35% 51
2020
Q1
$638K Sell
8,375
-537
-6% -$45.7K 0.35% 49
2019
Q4
$789K Sell
8,912
-307
-3% -$25.5K 0.34% 54
2019
Q3
$698K Buy
9,219
+845
+10% +$57.9K 0.33% 53
2019
Q2
$609K Sell
8,374
-437
-5% -$34.3K 0.29% 71
2019
Q1
$710K Sell
8,811
-71
-0.8% -$5.81K 0.36% 62
2018
Q4
$819K Buy
+8,882
New +$781K 0.47% 46

Other funds holding ABBV